BTCC / BTCC Square / Global Cryptocurrency /
Johnson & Johnson Faces Legal and Growth Challenges Amid Market Lag

Johnson & Johnson Faces Legal and Growth Challenges Amid Market Lag

Published:
2025-08-02 10:51:01
9
1
BTCCSquare news:

Johnson & Johnson (JNJ 1.53%), a healthcare giant by market cap, has underperformed the market in recent years. Persistent legal battles over talc-based products and looming patent expirations threaten its revenue stability. The company's attempt to settle lawsuits via bankruptcy maneuvers has faced judicial rejection, prolonging brand damage.

Key growth inhibitors include the loss of U.S. patent exclusivity for Stelara, a blockbuster immunosuppressant, and new Medicare pricing policies. These factors compound investor skepticism about J&J's long-term prospects in an increasingly competitive pharmaceutical landscape.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users